Home/Filings/4/0001209191-15-067186
4//SEC Filing

CATALYST BIOSCIENCES, INC. 4

Accession 0001209191-15-067186

$GYRECIK 0001124105operating

Filed

Aug 19, 8:00 PM ET

Accepted

Aug 20, 6:13 PM ET

Size

13.5 KB

Accession

0001209191-15-067186

Insider Transaction Report

Form 4
Period: 2015-08-20
Payne Fletcher
Chief Financial Officer
Transactions
  • Other

    Stock Option (Right to Buy)

    2015-08-20+7,3207,320 total
    Exercise: $7.60Exp: 2025-01-22Common Stock (7,320 underlying)
  • Other

    Stock Option (Right to Buy)

    2015-08-20+14,32514,325 total
    Exercise: $6.03Exp: 2025-05-08Common Stock (14,325 underlying)
  • Other

    Stock Option (Right to Buy)

    2015-08-20+2,4402,440 total
    Exercise: $7.60Exp: 2025-01-22Common Stock (2,440 underlying)
  • Other

    Common Stock

    2015-08-20+15,03215,032 total(indirect: By Trust)
Footnotes (4)
  • [F1]Represents shares of the Issuer issued pursuant to that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of March 5, 2015 as amended on May 6 and May 13, 2015, by and among the Issuer, Talos Merger Sub, Inc. and a Delaware corporation then known as Catalyst Biosciences, Inc. ("Old Catalyst"). Pursuant to the terms of the Merger Agreement, each share of common stock of Old Catalyst was converted into 0.0382 shares of the Issuer's common stock.
  • [F2]On January 22, 2015, Reporting Person was granted an option to purchase 191,635 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 7,320 shares of the Catalyst's common stock at a per share exercise price of $7.60. The option is fully vested and exercisable.
  • [F3]On January 22, 2015, Reporting Person was granted an option to purchase 63,878 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.29 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 2,440 shares of the Catalyst's common stock at a per share exercise price of $7.60. The option is fully vested and exercisable.
  • [F4]On May 8, 2015, Reporting Person was granted an option to purchase 375,000 shares of the common stock of Old Catalyst under Old Catalyst's Out of Plan Options at an exercise price of $0.23 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 14,325 shares of the Catalyst's common stock at a per share exercise price of $6.03. Subject generally to the Reporting Person's continued employment, the option vests at the rate of 1/48th of the number of shares on the 1st of each month with the first month vesting on May 1, 2015.

Issuer

CATALYST BIOSCIENCES, INC.

CIK 0001124105

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001124105

Filing Metadata

Form type
4
Filed
Aug 19, 8:00 PM ET
Accepted
Aug 20, 6:13 PM ET
Size
13.5 KB